Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

VEGF Trap-Eye improves retinal thickness and visual acuity in wet AMD

March 29, 2007

Jerini establishes ophthalmic subsidiary

March 23, 2007

POT-4 enters clinical development for AMD

March 21, 2007

Novel treatment strategy for glaucoma and ocular hypertension claimed by Allergan

March 15, 2007

Financing at Potentia to support AMD program

March 9, 2007

TG-100801 completes first phase I study for macular degeneration

March 2, 2007

Merck Frosst and Nippon Soda patents disclose new agents for treating eye disorders

March 2, 2007

Treatment begins in pivotal program for LX-211 in uveitis

Feb. 22, 2007

Inspire to commercialize AzaSite in U.S. and Canada

Feb. 20, 2007

AzaSite Plus well tolerated in phase I study

Feb. 15, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...